Showing results (231-240 of 322) with videos related to

Sort By:
Pageof 33
Journal of Korean Medical Science|October 14, 2003
High dose therapy followed by autologous peripheral blood stem cell transplantation as a first line treatment for multiple myeloma: a Korean Multicenter StudySoo-Mee Bang, Eun Kyung Cho, Cheolwon Suh, et al.
Annals of Hematology|April 6, 2018
Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysisJung Yong Hong, Dok Hyun Yoon, Cheolwon Suh, et al.
Annals of Hematology|December 17, 2009
Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP)Hyeon-Seok Eom, Yeo-Kyeoung Kim, Joo-Seop Chung, et al.
International Journal of Radiation Oncology, Biology, Physics|June 28, 2003
Phase II study of three-dimensional conformal radiotherapy and concurrent mitomycin-C, vinblastine, and cisplatin chemotherapy for Stage III locally advanced, unresectable, non-small-cell lung cancerSang-wook Lee, Eun Kyung Choi, Jung Shin Lee, et al.
International Journal of Cancer|August 9, 2011
Matched-pair analysis comparing the outcomes of primary breast and nodal diffuse large B-cell lymphoma in patients treated with rituximab plus chemotherapyHo-Young Yhim, Jin Seok Kim, Hye Jin Kang, et al.
Acta Haematologica|December 20, 2011
Primary thyroid marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type: clinical manifestation and outcome of a rare disease - consortium for improving survival of lymphoma studySung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Blood Research|October 11, 2016
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working PartySeok Jin Kim, Soo-Mee Bang, Yoon Seok Choi, et al.
Blood Research|July 5, 2013
Clinical features and survival outcomes of patients with diffuse large B-cell lymphoma: analysis of web-based data from the Korean Lymphoma Working Party RegistryHyeon Gyu Yi, Jin Seok Kim, Cheolwon Suh, et al.
Annals of Hematology|June 21, 2014
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II studySeok Jin Kim, Deok-Hwan Yang, Jin Seok Kim, et al.
Leukemia & Lymphoma|January 19, 2008
Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphomaByeong-Bae Park, Jin Seok Kim, Young-Yuel Lee, et al.
Pageof 33